These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14572168)

  • 21. Immunochemical study of connectin (titin) in neuromuscular diseases using a monoclonal antibody: connectin is degraded extensively in Duchenne muscular dystrophy.
    Matsumura K; Shimizu T; Nonaka I; Mannen T
    J Neurol Sci; 1989 Nov; 93(2-3):147-56. PubMed ID: 2592979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy.
    Carmignac V; Salih MA; Quijano-Roy S; Marchand S; Al Rayess MM; Mukhtar MM; Urtizberea JA; Labeit S; Guicheney P; Leturcq F; Gautel M; Fardeau M; Campbell KP; Richard I; Estournet B; Ferreiro A
    Ann Neurol; 2007 Apr; 61(4):340-51. PubMed ID: 17444505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biophysical characterization of naturally occurring titin M10 mutations.
    Rudloff MW; Woosley AN; Wright NT
    Protein Sci; 2015 Jun; 24(6):946-55. PubMed ID: 25739468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degradation of connectin (titin) in Fukuyama type congenital muscular dystrophy: immunochemical study with monoclonal antibodies.
    Matsumura K; Shimizu T; Sunada Y; Mannen T; Nonaka I; Kimura S; Maruyama K
    J Neurol Sci; 1990 Sep; 98(2-3):155-62. PubMed ID: 2243226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and selective disappearance of telethonin protein from the sarcomere in neurogenic atrophy.
    Schröder R; Reimann J; Iakovenko A; Mues A; Bönnemann CG; Matten J; Gautel M
    J Muscle Res Cell Motil; 2001; 22(3):259-64. PubMed ID: 11763198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly of titin, myomesin and M-protein into the sarcomeric M band in differentiating human skeletal muscle cells in vitro.
    van der Ven PF; Fürst DO
    Cell Struct Funct; 1997 Feb; 22(1):163-71. PubMed ID: 9113403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing Role of Titin Mutations in Neuromuscular Disorders.
    Savarese M; Sarparanta J; Vihola A; Udd B; Hackman P
    J Neuromuscul Dis; 2016 Aug; 3(3):293-308. PubMed ID: 27854229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical phenotypes in titinopathies explained by second titin mutations.
    Evilä A; Vihola A; Sarparanta J; Raheem O; Palmio J; Sandell S; Eymard B; Illa I; Rojas-Garcia R; Hankiewicz K; Negrão L; Löppönen T; Nokelainen P; Kärppä M; Penttilä S; Screen M; Suominen T; Richard I; Hackman P; Udd B
    Ann Neurol; 2014 Feb; 75(2):230-40. PubMed ID: 24395473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of distinct classes of titin isoforms in striated and smooth muscles by alternative splicing, and their conserved interaction with filamins.
    Labeit S; Lahmers S; Burkart C; Fong C; McNabb M; Witt S; Witt C; Labeit D; Granzier H
    J Mol Biol; 2006 Sep; 362(4):664-81. PubMed ID: 16949617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An N-terminal fragment of titin coupled to green fluorescent protein localizes to the Z-bands in living muscle cells: overexpression leads to myofibril disassembly.
    Turnacioglu KK; Mittal B; Dabiri GA; Sanger JM; Sanger JW
    Mol Biol Cell; 1997 Apr; 8(4):705-17. PubMed ID: 9247649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perturbation of the titin/MURF1 signaling complex is associated with hypertrophic cardiomyopathy in a fish model and in human patients.
    Higashikuse Y; Mittal N; Arimura T; Yoon SH; Oda M; Enomoto H; Kaneda R; Hattori F; Suzuki T; Kawakami A; Gasch A; Furukawa T; Labeit S; Fukuda K; Kimura A; Makino S
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31628103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysferlin and muscular dystrophy.
    Bushby KM
    Acta Neurol Belg; 2000 Sep; 100(3):142-5. PubMed ID: 11098285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins.
    Toro C; Olivé M; Dalakas MC; Sivakumar K; Bilbao JM; Tyndel F; Vidal N; Farrero E; Sambuughin N; Goldfarb LG
    BMC Neurol; 2013 Mar; 13():29. PubMed ID: 23514108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kinase domain of titin controls muscle gene expression and protein turnover.
    Lange S; Xiang F; Yakovenko A; Vihola A; Hackman P; Rostkova E; Kristensen J; Brandmeier B; Franzen G; Hedberg B; Gunnarsson LG; Hughes SM; Marchand S; Sejersen T; Richard I; Edström L; Ehler E; Udd B; Gautel M
    Science; 2005 Jun; 308(5728):1599-603. PubMed ID: 15802564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
    Hackman P; Marchand S; Sarparanta J; Vihola A; Pénisson-Besnier I; Eymard B; Pardal-Fernández JM; Hammouda el-H; Richard I; Illa I; Udd B
    Neuromuscul Disord; 2008 Dec; 18(12):922-8. PubMed ID: 18948003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebulin and titin expression in Duchenne muscular dystrophy appears normal.
    Fürst D; Nave R; Osborn M; Weber K; Bardosi A; Archidiacono N; Ferro M; Romano V; Romeo G
    FEBS Lett; 1987 Nov; 224(1):49-53. PubMed ID: 3678494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional properties of the titin/connectin-associated proteins, the muscle-specific RING finger proteins (MURFs), in striated muscle.
    Gregorio CC; Perry CN; McElhinny AS
    J Muscle Res Cell Motil; 2005; 26(6-8):389-400. PubMed ID: 16477476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
    Bos JM; Poley RN; Ny M; Tester DJ; Xu X; Vatta M; Towbin JA; Gersh BJ; Ommen SR; Ackerman MJ
    Mol Genet Metab; 2006 May; 88(1):78-85. PubMed ID: 16352453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish.
    Zou J; Tran D; Baalbaki M; Tang LF; Poon A; Pelonero A; Titus EW; Yuan C; Shi C; Patchava S; Halper E; Garg J; Movsesyan I; Yin C; Wu R; Wilsbacher LD; Liu J; Hager RL; Coughlin SR; Jinek M; Pullinger CR; Kane JP; Hart DO; Kwok PY; Deo RC
    Elife; 2015 Oct; 4():e09406. PubMed ID: 26473617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A.
    Tagawa K; Taya C; Hayashi Y; Nakagawa M; Ono Y; Fukuda R; Karasuyama H; Toyama-Sorimachi N; Katsui Y; Hata S; Ishiura S; Nonaka I; Seyama Y; Arahata K; Yonekawa H; Sorimachi H; Suzuki K
    Hum Mol Genet; 2000 May; 9(9):1393-402. PubMed ID: 10814721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.